Apellis Pharmaceuticals Given New 47.00 Price Target at Bank of America
| PARDDelisted Stock | USD 0.01 0.00 0.00% |
About 56% of Poniard Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Poniard Pharmaceuticals pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Poniard Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Poniard Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Poniard Pharmaceuticals pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Poniard daily returns and investor perception about the current price of Poniard Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Poniard |
Apellis Pharmaceuticals had its price objective cut by Bank of America from 61.00 to 47.00 in a research note released on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. Other analysts also recently issued research reports about the stock. William Blair began coverage on shares of
Read at thelincolnianonline.com
 |
Poniard Pharmaceuticals Fundamental Analysis
We analyze Poniard Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Poniard Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Poniard Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Poniard Pharmaceuticals is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Poniard Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Poniard Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Poniard Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Poniard Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Poniard Pharmaceuticals Related Equities
| XLO | Xilio Development | 7.92 | ||||
| SRRK | Scholar Rock | 4.59 | ||||
| ADPT | Adaptive Biotechnologies | 3.66 | ||||
| IKNA | Ikena Oncology | 2.37 | ||||
| VIR | Vir Biotechnology | 1.27 | ||||
| BCYC | Bicycle Therapeutics | 0.25 | ||||
| APLS | Apellis Pharmaceuticals | 0.62 | ||||
| CYTK | Cytokinetics | 0.69 | ||||
| CRNX | Crinetics Pharmaceuticals | 0.81 | ||||
| TARA | Protara Therapeutics | 0.99 | ||||
| LEGN | Legend Biotech | 2.46 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Poniard Pink Sheet
If you are still planning to invest in Poniard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Poniard Pharmaceuticals' history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |